Comparative Evaluation of Select Serological Assays for Zika Virus Using Blinded Reference Panels
Viruses · 2024
DOI: 10.3390/v16071075 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Viruses, 2024. Verfasst von Devy M Emperador und 10 weiteren Autor:innen. Beteiligte Einrichtung: Pandemic Threats Programme, Foundation for Innovative New Diagnostics (FIND), 1218 Geneva, Switzerland. Hauptthemen laut MEDLINE: Zika Virus, Zika Virus Infection, Antibodies, Viral, Sensitivity and Specificity. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: World Health Organization, CDC HHS, NHLBI NIH HHS.
Abstract (Originalsprache)
In response to the 2015 Zika virus (ZIKV) epidemic that occurred in Brazil, numerous commercial serological assays have been developed for clinical and research applications. Diagnosis of recent infection in pregnant women remains challenging. Having standardized, comparative studies of ZIKV tests is important for implementing optimal diagnostic testing and disease surveillance. This is especially important for serology tests used to detect ZIKV infection given that antibodies against ZIKV can cross-react with other arboviruses in the same virus family, such as dengue virus (DENV), yellow fever virus (YFV) and West Nile virus (WNV). We looked at the sensitivity and specificity of tests detecting ZIKV antibodies (IgM, IgG) from multiple manufacturers using panels of samples previously collected with known exposure to ZIKV and other arboviruses. We found that performance of the IgM tests was highly variable, with only one test (Inbios 2.0 IgM capture ELISA) having both high sensitivity and specificity. All IgG tests showed good sensitivity; however, specificity was highly variable, with some assays giving false-positive results on samples infected by another flavivirus. Overall, the results confirmed that accurate ZIKV antibody testing is challenging, especially in specimens from regions endemic for multiple other flaviviruses, and highlight the importance of available and suitable reference samples to evaluate ZIKV diagnostics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Pandemic Threats Programme, Foundation for Innovative New Diagnostics (FIND), 1218 Geneva, Switzerland.
- Vitalant Research Institute, San Francisco, CA 94105, USA.
- Department of Laboratory Medicine, University of California San Francisco, San Francisco, CA 94143, USA.
- Epidemic and Pandemic Preparedness and Prevention Department, Health Emergencies Programme, World Health Organization, 1211 Geneva, Switzerland.
ORCID-Profile: Devy M Emperador, Mars Stone, Eduard Grebe, Camille Escadafal, Cassandra Kelly-Cirino, Diana P Rojas, Michael P Busch, Graham Simmons
Förderung
- World Health Organization
- CDC HHS
- NHLBI NIH HHS
- National Heart, Lung and Blood Institute (NHLBI) Recipient Epidemiology and Donor Evaluation Study (REDS-III) program
- Centers for Disease Control and Prevention
Zitieren
APA
Emperador, D. M., Stone, M., Grebe, E., Escadafal, C., Dave, H., Lackritz, E., Kelly-Cirino, C., Rabe, I., Rojas, D. P., Busch, M. P., & Simmons, G. (2024). Comparative Evaluation of Select Serological Assays for Zika Virus Using Blinded Reference Panels. Viruses. https://doi.org/10.3390/v16071075
Vancouver
Emperador DM, Stone M, Grebe E, Escadafal C, Dave H, Lackritz E, et al. Comparative Evaluation of Select Serological Assays for Zika Virus Using Blinded Reference Panels. Viruses. 2024. doi:10.3390/v16071075
BibTeX
@article{Emperador2024,
author = {Emperador, Devy M and Stone, Mars and Grebe, Eduard and Escadafal, Camille and Dave, Honey and Lackritz, Eve and Kelly-Cirino, Cassandra and Rabe, Ingrid and Rojas, Diana P and Busch, Michael P and Simmons, Graham},
title = {Comparative Evaluation of Select Serological Assays for Zika Virus Using Blinded Reference Panels},
journal = {Viruses},
year = {2024},
doi = {10.3390/v16071075}
}
EUVIMED